← Back
$BMY All transactions

BRISTOL MYERS SQUIBB CO

A

$ Value

$0

Shares

729

Price

$0

Filed

Jul 1

Insider

Name

Arduini Peter J

Title

CIK

0001323134

Roles

Director

Transaction Details

Transaction Date

2025-06-30

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

62,989

Footnotes

Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. | Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Filing Info

Accession No.

0000014272-25-000125

Form Type

4

Issuer CIK

0000014272

Arduini Peter J's History

Date Ticker Type Value
2026-03-31 BMY A $35K
2026-03-02 GEHC A $0
2026-03-02 GEHC A $0
2026-02-12 GEHC A $0
2026-02-12 GEHC F $2.6M
2026-02-01 BMY A $220K
2026-02-01 GEHC F $253K
2025-12-31 BMY A $0
2025-09-30 BMY A $0
2025-09-01 GEHC F $433K

Other Insiders at BMY (90d)

Insider Bought Sold Last
YALE PHYLLIS R 2026-03-31
Arduini Peter J 2026-03-31
Rice Derica W 2026-03-31
Price Paula A 2026-02-01
McMullen Michael R. 2026-03-31
Elkins David V
EVP, Chief Financial Officer
$1.9M 2026-04-01
BOERNER CHRISTOPHER S.
Chief Executive Officer
2026-03-10
Haller Julia A 2026-02-01
Samuels Theodore R. II 2026-03-31
Vousden Karen H 2026-02-01
Hickey Benjamin
President, RayzeBio Org.
2026-03-10
Plenge Robert M
EVP, Chief Research Officer
2026-03-10
Hidalgo Medina Manuel 2026-02-01
Meyers Gregory Scott
EVP, Chief Digital & Tech Off.
2026-03-10
Shanahan Karin
EVP, Chief Supply Chain & Ops
2026-04-01
Bhatt Deepak 2026-02-01
Lenkowsky Adam
EVP, Chief Commercial Officer
2026-03-10
Gallman Cari
EVP, General Counsel
2026-03-10
Poole Ahn Amanda
EVP, Chief People Officer
2026-03-10
Hoch Lynelle
President, Cell Therapy Org.
2026-03-10
Holzer Phil M
SVP and Controller
2026-03-10
Short Bartie Wendy
EVP, Corporate Affairs
2026-03-10
Shibutani Hiroshi Chris
EVP, Chief Strategy Officer
2026-03-10
Massacesi Cristian
EVP,Chief Med Offr,Head of Dev
2026-03-10